medical equipment supplies+91 9072522062 medical device companies+91 8891199950
Tetrilimus | SMT

Tetrilimus | SMT

Tetrilimus is an advanced everolimus-eluting cobalt-chromium coronary stent system developed by Sahajanand Medical Technologies (SMT). Featuring an innovative Tetrinium platform, ultrathin stent struts, and a unique biodegradable polymer coating, Tetrilimus is designed to provide enhanced flexibility, deliverability, and structural integrity. Its biphasic drug-release technology supports controlled everolimus delivery while maintaining coating integrity and promoting vascular healing.

Features

Features a cobalt-chromium stent platform with ultrathin strut design, engineered to provide flexibility, deliverability, and reliable vessel support.
Incorporates a unique biodegradable polymer matrix combining hydrophilic and hydrophobic polymers to ensure controlled drug release and excellent coating integrity.
Utilizes everolimus at a drug dose of 1.0 μg/mm², with approximately 80% drug release within four weeks and complete release over approximately three months.
Designed to provide enhanced flexibility in the crimped state, supporting improved trackability, pushability, and conformability during delivery.
Features a multilayer coating system designed to provide controlled drug-release kinetics and maintain effective drug levels within arterial tissues.
Incorporates an advanced stent architecture designed to support flexibility, conformability, and consistent performance across different coronary vessel anatomies.
healthcare equipment